The Simcyp Consortium [V2 DRAFT ONLY]

The Simcyp Division of Certara UK Limited was founded as Simcyp Limited in 2001 by Professors Geoff Tucker and Amin Rostami-Hodjegan as a spin-out company from the University of Sheffield, UK. Simcyp was acquired by Certara in 2012 with its name changing to Certara UK (Simcyp Division) in 2018 and has continued experience dynamic growth. […]

Read More
Topics:

Princeton Workshops: September 2019

Model-informed Drug Development Incorporating population variability into mechanistic prediction of PK and modeling PK/PD October 14 – 18 in Princeton, USA Focused workshops offer an in-depth insight into specific areas of modeling such as: Transporter-related ADMET Absorption and pharmaceutical issues Pediatric drug development Parameter estimation (PE) and pharmacodynamics (PD) Complex drug-drug interactions (DDIs) Biologics PBPK […]

Read More
Topics:

Washington DC Workshops: September 2019

Model-informed Drug Development Incorporating population variability into mechanistic prediction of PK and modeling PK/PD March 23 – 26 in Washington DC Focused workshops offer an in-depth insight into specific areas of modeling such as: Transporter-related ADMET Absorption and pharmaceutical issues Pediatric drug development Parameter estimation (PE) and pharmacodynamics (PD) Complex drug-drug interactions (DDIs) Biologics PBPK […]

Read More
Topics:

Sheffield, UK Workshops: September 2019

Model-informed Drug Development Incorporating population variability into mechanistic prediction of PK and modeling PK/PD September 16 – 17 in Sheffield, UK Focused workshops offer an in-depth insight into specific areas of modeling such as: Transporter-related ADMET Absorption and pharmaceutical issues Pediatric drug development Parameter estimation (PE) and pharmacodynamics (PD) Complex drug-drug interactions (DDIs) Biologics PBPK […]

Read More
Topics:

20th Annual Simcyp Consortium Meeting

September 17–19 in Sheffield, UK Each year, the Simcyp Consortium of leading pharmaceutical and biotechnology companies meet to discuss the latest scientific developments in the area of modeling and simulation and guide the future development of the Simcyp Population-based Simulator. This year’s event will open with an evening welcome reception on Tuesday. How do I […]

Read More
Topics:

Shanghai, China Workshop: November 2019

Model-informed Drug Development Incorporating population variability into mechanistic prediction of PK and modeling PK/PD November 12–13 & 14–15 in Shanghai, China Focused workshops offer an in-depth insight into specific areas of modeling such as: Transporter-related ADMET Absorption and pharmaceutical issues Pediatric drug development Parameter estimation (PE) and pharmacodynamics (PD) Complex drug-drug interactions (DDIs) Biologics PBPK […]

Read More
Topics:

Hyderabad Workshop: April 2019

Intensive 3-day Workshop on MIDD April 9–11 in Hyderabad, India Certara-Simcyp Hands-on Workshop This tailored workshop on in vitro-in vivo extrapolation of metabolism, transport, and biopharmaceutics includes hands-on exercises using the industry standard Simcyp Population-based Simulator for PBPK modeling, formulation development, and DDI predictions. This workshop is intended for scientists working in discovery DMPK, metabolism, […]

Read More
Topics:

Krakow Workshop: May 2019

Intensive 5-day Workshop on MIDD May 13–17 in Krakow, Poland Certara-Simcyp Full Workshop Incorporating population variability into mechanistic prediction of PK and modeling PK/PD Delegates will learn how to simulate and predict: Metabolic drug clearance (CL) Metabolic drug-drug interactions (DDIs) Gut first-pass metabolism Oral drug absorption incorporating food effects and the impact of dosage form […]

Read More
Topics:

Seattle Workshop: June 2019

Intensive 5-day Workshop on MIDD June 24–28 in Seattle, USA Certara-Simcyp Full Workshop Incorporating population variability into mechanistic prediction of PK and modeling PK/PD Delegates will learn how to simulate and predict: Metabolic drug clearance (CL) Metabolic drug-drug interactions (DDIs) Gut first-pass metabolism Oral drug absorption incorporating food effects and the impact of dosage form […]

Read More
Topics:
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog